Archives

by in
Entry Author Date Location
Amicus Shelves New-Drug Filing For Fabry Disease Drug 06/17/13 New York
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) 05/14/13 National
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
Nimbus Discovery, Shire to Co-Develop Oral Rare Disease Drugs 05/08/13 Boston
Former Keryx Exec’s Mission: Turn TG Into the Next Pharmacyclics 05/06/13 New York
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
Bay State Newbies from J&J, PayPal, and More Gather in Kendall Square 04/11/13 Boston
Foundation-Backed Dart Revs Up, Seeks Venture Funds 03/29/13 Boston
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Veracyte Wins Over UnitedHealth With Thyroid Cancer Diagnostic 03/08/13 San Francisco
Someone Needs to Rank U.S. Biotech Hubs, For Real 03/04/13 National
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
San Diego Life Sciences Roundup: Isis, Afraxis, Organovo, & More 01/31/13 San Diego
FDA OKs First-in-Class Drug From Isis for Rare Cholesterol Disorder 01/29/13 San Diego
Keryx Finally Succeeds With a Clinical Trial, for Kidney Disease Drug 01/28/13 New York
The Wisconsin Biotech Story: Slow and Steady Wins the Race 12/10/12 National
NanoString Pockets $15.3M For Diagnostic Rollout 12/04/12 Seattle
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
Radius Fourth Boston-area Biotech This Year Going for IPO 10/24/12 Boston
Alnylam Gets $22.5M From Genzyme for Asia Rights to Amyloidosis Drug 10/22/12 Boston
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Two Years After Rising from Ashes, Aegerion Preps for Drug Debut 08/09/12 Boston
Page 1 of 14 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.